Testosterone Science

FDA, Regulation and Guidelines

Women Turn to Testosterone for Low Sex Drive as Doctors Confront Treatment ‘Experimentation’

Specific Claim Evaluated

Guidelines support testosterone in women for only 1 indication, hypoactive sexual desire disorder, and evidence for energy, mood, bone health or sleep remains limited; no testosterone product is FDA approved for women.

Primary Research Supporting or Contradicting the Claim

The consensus statement identifies hypoactive sexual desire disorder as the only evidence-based indication (Davis et al., 2019).

Corrected Evidence-Based Interpretation

The report is correct.

Rationale for Grade

The article reports the indication and regulatory status accurately and illustrates the difficulty of dosing male products for women.

References

  1. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
    Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD."

Post a Comment

Shared Decision Making

Bring the Evidence to Your Next Consultation

Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.